ASX:4DX

4DMedical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive 4DX News and Ratings via Email

Sign-up to receive the latest news and ratings for 4DMedical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9545 5940
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$283,229.00
Book ValueA$0.18 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

About 4DMedical

4DMedical Limited operates as a software technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with University of Miami Health System to establish the functional lung imaging research program. The company was founded in 2012 and is based in Melbourne, Australia.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











4DMedical (ASX:4DX) Frequently Asked Questions

What stocks does MarketBeat like better than 4DMedical?

Wall Street analysts have given 4DMedical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 4DMedical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are 4DMedical's key executives?

4DMedical's management team includes the following people:
  • Dr. Andreas Fouras M.A.I.C.D., Ph.D., Founder, MD, CEO & Exec. Director
  • Mr. Heath Lee C.A., Chief Financial Officer
  • Mr. Craige Pendleton-Browne, Chief Information Officer
  • Mr. Paul Cooke, Sr. VP of Sales & Marketing
  • Dr. Aidan Jamison B.E., Ph.D., Sr. VP of Engineering
  • Dr. Michael Curtis, Chief Software Architect
  • Ms. Charlene Stahr, Company Sec.
  • Ms. Ming Lam B.Com., CPA, Financial Controller

Who are some of 4DMedical's key competitors?

What is 4DMedical's stock symbol?

4DMedical trades on the ASX under the ticker symbol "4DX."

How much money does 4DMedical make?

4DMedical has a market capitalization of $0.00 and generates $283,229.00 in revenue each year.

How many employees does 4DMedical have?

4DMedical employs 41 workers across the globe.

What is 4DMedical's official website?

The official website for 4DMedical is www.4dmedical.com.

How can I contact 4DMedical?

The company can be reached via phone at 61 3 9545 5940.


This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.